Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.9867
-0.0233 (-2.31%)
At close: May 12, 2025, 4:00 PM
0.9999
+0.0132 (1.34%)
After-hours: May 12, 2025, 7:56 PM EDT
Immunic Market Cap
Immunic has a market cap or net worth of $94.54 million as of May 12, 2025. Its market cap has decreased by -15.21% in one year.
Market Cap
94.54M
Enterprise Value
59.88M
1-Year Change
-15.21%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since April 17, 2014, Immunic's market cap has decreased from $253.40M to $94.54M, a decrease of -62.69%. That is a compound annual growth rate of -8.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 91.10M | 1.11% |
| Dec 31, 2024 | 90.10M | 33.09% |
| Dec 29, 2023 | 67.70M | 23.09% |
| Dec 30, 2022 | 55.00M | -78.11% |
| Dec 31, 2021 | 251.20M | -20.71% |
| Dec 31, 2020 | 316.80M | 222.94% |
| Dec 31, 2019 | 98.10M | 1,141.77% |
| Dec 31, 2018 | 7.90M | -96.85% |
| Dec 29, 2017 | 251.10M | 80.13% |
| Dec 30, 2016 | 139.40M | -60.23% |
| Dec 31, 2015 | 350.50M | -41.04% |
| Dec 31, 2014 | 594.50M | 134.61% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |